MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer

Clinical and Experimental Metastasis

Volumn 22, Issue 7, 2005, Pages 565-573

  Cozzi, Paul J ^a,b   Wang, Jian ^a,b   Delprado, Warick ^c   Perkins, Alan C ^d   Allen, Barry J ^a,b   Russell, Pamela J ^b,e   Li, Yong ^a,b  

^a ST GEORGE HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c DOUGLASS HANLY MOIR PATHOLOGY   (Australia)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Human prostate cancer; Monoclonal antibodies; Mucins; Tissue microarray; Tumor associated antigen

Indexed keywords

MONOCLONAL ANTIBODY; MUCIN 1; MUCIN 2; MUCIN 4; MUCIN 5AC; MUCIN 6; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; GENE OVEREXPRESSION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PROSTATE CANCER; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUCINS; PROSTATIC NEOPLASMS;

EID: 32544441378     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-005-5376-z     Document Type: Article

References (53)

1. A Jemal T Murray A Samuels 2003 Cancer statistics, 2003 CA Cancer J Clin 53 5 26
2. MA Hollingsworth BJ Swanson 2004 Mucins in cancer: protection and control of the cell surface Nat Rev 4 45 60
3. ME Legrier GD Pinieux K Boye 2004 Mucinous differentiation features associated with hormonal escape in a human prostate cancer xenograft Br J Cancer 90 720 7
4. SB Ho GA Niehans Y Lyftogt 1993 Heterogeneity of mucin gene expression in normal and neoplastic tissues Cancer Res 53 641 51
5. DH Live LJ Williams SD Kuduk 1999 Probing cell-surface architecture through synthesis: an NMR-determined structural motif for tumor-associated mucins Pro Natl Acad Sci USA 96 3489 93
6. N Moniaux F Escande N Porchet 2001 Structural organization and classification of the human mucin genes Frontiers Biosci 6 D1192 206
7. MC Copin MP Buisine E Leteurtre 2001 Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas Human Pathol 32 274 81
8. CR Pound AW Partin MA Eisenberger 1999 Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1591 7
9. DF Gleason 1966 Classification of prostatic carcinomas Cancer Chemother Rep 50 125 8
10. FH Schroder P Hermanek L Denis 1992 The TNM classification of prostate cancer Prostate (Suppl) 4 129 138
11. J Kononen L Bubendorf A Kallioniemi 1998 Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 844 7
12. Y Li Z Tian SMA Rizvi 2002 In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213-labeled J591 antibody against the prostate specific membrane antigen Prostate Cancer Prostatic Dis 5 36 46
13. MA Rubin R Dunn M Strawderman 2002 Tissue microarray sampling stratergy for prostate cancer biomarker analysis Am J Surg Pathol 26 312 9
14. DL Rimm RL Camp LA Charette 2001 Amplification of tissue by construction of tissue microarrays Exp Mol Pathol 7 55 64
15. S Hakomori 1989 Aberrant glycosylation in tumors and tumor-associated carbohydrate antigen Adv Cancer Res 52 257 331
16. S Gendler J Taylor-Papadimitriou T Duhig 1988 A high immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats J Biol Chem 263 12820 3
17. IC Gaemers HL Vos HH Volders 2001 ASTAT-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells J Biol Chem 276 6191 9
18. I Bieche R Lidereau 1997 A gene dosage effect is responsible for high overexpression of the MUC1 gene observed in human breast tumors Cancer Genet Cytogenet 98 75 80
19. SJ Gendler AP Spicer 1995 Epithelial mucin genes Annu Rev Physiol 57 607 34
20. MD Burdick A Harris CJ Reid 1997 Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines J Biol Chem 272 24198 202
21. J Taylor-Papadimitriou J Burchell DW Miles 1999 MUC1 and cancer Biochim Biophys Acta 1455 301 13
22. FG Hanisch S Muller 2000 MUC1: the polymorphic appearance of a human mucin Glycobiology 10 439 49
23. J Wesseling SW Van der Valk HL Vos 1995 Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components J Cell Biol 129 255 65
24. K Konodo N Kohno A Yokoyama 1998 Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines Cancer Res 58 2014 9
25. H Feng M Ghazizadeh H Konishi 2002 Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas Jpn J Clin Oncol 32 525 9
26. J Wesseling SW Van der Valk J Hilkens 1996 A mechanism for inhibition of E-cadherin-mediated cell-cell adhesion by the membrane-associated mucin episialin/MUC1 Mol Biol Cell 7 565 77
27. KM [tmp] McDermott PR Crocker A Harris 2001 Overexpression of MUC1 reconfigures the binding properties of tumor cells Int J Cancer 94 783 91
28. K Zhang D Baeckstrom H Brevinge 1996 Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and × epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells J Cell Biochem 60 538 49
29. EC Brinkman-Van der Linden A Varki 2000 New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins. J Biol Chem 275 8625 32
30. P Pandey S Kharbanda D Kufe 1995 Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein Cancer Res 55 4000 3
31. Y Li A Bharti D Chen J Gong 1998 Interaction of glycogen synthase kinase 3b with the DF3/MUC1 carcinoma-associated antigen and β-catenin Mol Cell Biol 18 7216 24
32. ODM Hughes H Denley RB Kunkler 2000 MUC1 mucin expression in transitional cell carcinoma of the bladder J Urol Path 12 179 91
33. S Zhang HS Zhang VE Reuter 1998 Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers Clin Cancer Res 4 295 302
34. A Kirschenbaum SH Itzkowitz JP Wang 1999 MUC1 expression in prostate carcinoma: correlation with grade and stage Mol Urol 3 163 8
35. I Papadopoulos E Sivridis A Giatromanolaki 2001 Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer Clin Cancer Res 7 1533 8
36. T Arai K Fujita M Fujime 2005 Expression of sialylated MUC1 in prostate cancer: Relationship to clinical stage and prognosis Int J Urol 12 653 61
37. IC Schut PM Waterfall M Ross 2003 MUC1 expression, splice variant and short form transcription (MUC1/Z, MUC1/Y) in prostate cell lines and tissue BJU Int 91 278 83
38. JC O'Connor J Julian SD Lim 2005 MUC1 expression in human prostate cancer cell lines and primary tumors Prostate Cancer Prostatic Dis 8 36 44
39. L Lapointe CD Li JP Higgins 2004 Gene expression profiling identifies clinically relevant subtypes of prostate cancer Proc Natl Acad Sci USA 101 811 6
40. MA [tmp] McGucki MD Walsh BG Hohn 1995 Prognostic significance of MUC1 epithelial mucin expression in breast cancer Hum Pathol 26 432 9
41. M Sagara S Yonezawa K Nagata 1999 Expression of mucin 1 (MUC1) in esophageal squamous-cell carcinoma: its relationship with prognosis Int J Cancer 84 251 7
42. K Fujita K Denda M Yamamoto 1999 Expression of MUC1 mucin inversely correlated with post-surgical survival of renal cell carcinoma patients Br J Cancer 80 301 8
43. S Satoh Y Hinoda T Hayashi 2000 Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule Int J Cancer 88 507 18
44. Y Li SMA Rizvi JM Brown 2004 Antigenic expression human metastatic prostate cancer cell lines for in vitro multiple targeted alpha therapy 213Bi-conjugated Int J Radiat Oncol Biol Phys 60 896 908
45. 213Bi-C595 radioimmunoconjugate Br J Cancer 91 2086 93
46. C Doehn D Jocham 2000 Technology evaluation: TG-1031, transgene SA Curr Opin Mol Ther 2 106 11
47. MA Morse 2001 Technology evaluation: BLP-25, Biomira, Inc Curr Opin Mol Ther 3 102 5
48. AJ Pantuck A van Ophoven BJ Gitlitz 2004 Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer J Immunother 27 240 53
49. MA Hollingsworth JM Strawhecker TC Caffrey 1994 Expression of MUC1, MUC2, MUC3 and MUC4 mucin mRNAs in human pancreatic and intestinal tumour cell line Int J Cancer 57 198 203
50. MJ Swartz SK Batra GC Varshney 2002 MUC4 expression increases progressively in pancreatic intraepithelial neoplasia Am J Clin Pathol 117 791 6
51. M Komatsu L Tatum NH Altman 2000 Potentiation of metastasis by cell surface sialomucin complex (rat MUC4), a multifunctional anti-adhesive glycoprotein Int J Cancer 87 480 6
52. I Van Seuningen P Pigny M Perrais 2001 Transcriptional regulation of the 11p15 mucin genes: towards new biological tools in human therapy, in inflammatory disease and cancer? Front Biosci 6 D1216 34
53. X Leroy C Ballereau A Villers 2003 MUC6 is a marker of seminal vesicle-ejaculatory duct epithelium and is useful for the differential diagnosis with prostate adenocarcinoma Am J Surg Pathol 27 519 21